Results 201 to 210 of about 26,961 (258)

Humanization of Drug Metabolism in the <i>Plasmodium berghei</i> Mouse Model for Antimalarial Drug Discovery. [PDF]

ACS Infect Dis
MacLeod AK, Merino C, Viera-Morilla S, Frame L, Tavendale A, Duncan C, Ferguson L, Pinto EG, Simeons FRC, Gomez-Jimenez V, García AB, Riley J, Shishikura Y, Martínez-Martínez MS, Wolf CR, Read KD.   +15 more
europepmc   +1 more source

Hidden Infections, Emerging Resistance: Underdiagnosed Plasmodium vivax and Multidrug Resistance-1 (pvmdr1) Gene Amplification in the Guiana Shield. [PDF]

J Infect Dis
Puça MCSB, Mascarenhas MEP, Huguet QB, Salazar YEAR, Nogueira IR, Louzada J, de Pina-Costa A, de Siqueira AM, de Oliveira E Silva M, Pereira DB, Ladeia-Andrade S, Ferreira MU, Oliveira-Ferreira J, Gil JP, de Sousa TN.   +14 more
europepmc   +1 more source

Gaps in knowledge and use of artemether-lumefantrine among university students in Southwestern Nigeria: A cross-sectional study. [PDF]

PLoS One
Orok E, Olumoko O, Ekada I, Oladunni A.
europepmc   +1 more source

Diagnostic and therapeutic practices for paediatric malaria: Gap between guidelines and clinical reality in south-east Gabon. [PDF]

Malariaworld J
Biteghe-Bi-Essone JC, Imboumy-Limoukou RK, Noronha ID, Moukodoum DN, Ontoua SS, Atiga N, Kouna LC, Okouga AP, Lekana-Douki JB, Oyegue-Liabagui LS.   +9 more
europepmc   +1 more source

The urgent need for African research collaboration on medicine quality. [PDF]

Nat Commun
Zeng F, Mariwah S, Mshana G, Amoako-Sakyi D, Hamill H.   +4 more
europepmc   +1 more source

The accuracy of recording malaria rapid diagnostic test (RDT) results in public health facilities in Benin; results from the MaCRA project. [PDF]

Malar J
Ahogni I, Avanon H, Hueha C, Kpemasse A, Aissan J, Affoukou C, Accrombessi M, Aponte JJ, Hilton E, Cooper S, Griffith K, Humes M, Lindblade KA, Ngufor C.   +13 more
europepmc   +1 more source

Asymptomatic malaria: a hidden reservoir for the transmission and circulation of artemisinin partial-resistant <i>Plasmodium falciparum</i> in Tanzania. [PDF]

Emerg Microbes Infect
Mazigo E, Lee WJ, Jun H, Fitriana F, Syahada JH, Louis JM, Muh F, Lu F, Lee KJ, Nam JW, Han JH, Kwon TH, Lee SJ, Na S, Chun W, Park WS, Han ET, Todd J, Manjurano A, Kidima W, Han JH.   +20 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Antimalarials

Dermatologic Therapy, 2001
Antimalarial medications have become the parenteral drugs of choice for treating the cutaneous manifestations of lupus erythematosus. The immune-modulating activity of these agents makes them useful in a variety of other dermatoses. With prudent dosage and monitoring, these agents can be used safely and effectively in the treatment and management of ...
M J, Van Beek, W W, Piette
openaire   +2 more sources

The antimalarial pipeline

Current Opinion in Pharmacology, 2018
Over the past decade, new high-throughput phenotypic assays with malaria parasites have been developed, and these were used to screen millions of compounds. This effort, as well as improving older chemical scaffolds and optimising compounds against both known and new drug targets has resulted in the discovery of exciting new pipeline drug candidates ...
Rob, Hooft van Huijsduijnen, Timothy Nc, Wells   +1 more
openaire   +2 more sources

Antimalarial combinations

The Lancet, 2004
Multidrug resistance has rendered monotherapy for malaria useless in most parts of the world, and has also compromised the usefulness of many of the available combination chemotherapies. New antimalarial regimens are, therefore, urgently needed. We review the various antimalarial combinations that can be used to treat otherwise drug-resistant disease ...
Peter Gottfried, Kremsner, Sanjeev, Krishna   +1 more
openaire   +2 more sources